Dementia gene raises risk of severe COVID-19
Having a faulty gene linked to dementia doubles the risk of developing severe COVID-19, according to a large-scale study. Researchers at the University of Exeter...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Having a faulty gene linked to dementia doubles the risk of developing severe COVID-19, according to a large-scale study. Researchers at the University of Exeter...
A type of personalized care known as precision medicine, and its subset, genomic medicine, is now the standard of care in Connecticut’s Hartford HealthCare Cancer Institute, UConn...
“Black Lives Matter and BioCT is committed to addressing racism through members’ employment practices, their development of therapeutics to benefit all patients and our support of...
Pfizer is establishing the Pfizer Breakthrough Growth Initiative, through which Pfizer will invest up to $500 million in biotechnology companies to help provide funding and...
As Connecticut continues to face one of the world’s deadliest COVID-19 outbreaks, the state’s bioscience industry has aggressively turned its focus to developing new breakthrough...
LambdaVision has been selected by NASA for a Small Business Innovation Research (SBIR) Phase II award, worth $750,000 over two years. With the continued support...
InveniAI® LLC has formed a strategic partnership with TB Alliance, a non-profit organization dedicated to the discovery, development, and delivery of better, faster-acting and affordable...
Architectural Building Systems is a multi-generational General Contracting and Construction Management firm that was founded in 1985 to serve the ever-changing needs of customers in...
Plans for a new 10-story, 500,000-square-foot bioscience building in downtown New Haven to feature lab, research, and incubator space have garnered a key approval. The...
Tangen Biosciences and LabWare have agreed to enter into an exclusive partnership whereby LabWare will distribute Tangen’s GeneSpark™ device as part of the LabWare’s Portable Disease...